Clinical Trial Update: Lapatinib and Bevacizumab for Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating lapatinib and bevacizumab in metastatic breast cancer; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Neoplasms

Drugs mentioned

• Bevacizumab (bevacizumab)
• Lapatinib (Lapatinib)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Neoplasms, Breast | Phase 2 | Status: COMPLETED | Results posted: 2009-08-20